PVLA
Palvella Therapeutics
PVLA
PVLA
68 hedge funds and large institutions have $68.3M invested in Palvella Therapeutics in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 26 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 15
41% less capital invested
Capital invested by funds: $115M → $68.3M (-$46.6M)
46% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 26
Holders
68
Holding in Top 10
2
Calls
$222K
Puts
$24K
Top Buyers
| 1 | +$3.9M | |
| 2 | +$836K | |
| 3 | +$586K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$398K |
| 5 |
Renaissance Technologies
New York
|
+$384K |
Top Sellers
| 1 | -$4.81M | |
| 2 | -$1.26M | |
| 3 | -$909K | |
| 4 |
Millennium Management
New York
|
-$828K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$630K |